In conclusion, our present findings show that anti-miR-146b-3p could restore radioiodine uptake in dedifferentiated thyroid cancer by up-regulating NIS expression and translocation to the cell membrane in vitro by targeting MUC20 through MET Signaling pathways. Here, MUC20 is linked to thyroid cancer.